Drug Type CAR-NK |
Synonyms CD147-CAR-NK |
Target |
Action inhibitors |
Mechanism BSG inhibitors(Basigin inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatocellular Carcinoma | Preclinical | United States | 23 Sep 2020 |





